Supply Chain Consolidation In Europe Poses Drugmaker Challenges
Pharma & Healthcare / Europe / Wed 25 Jul, 2018
Key View:
- Increased cost-containment across Europe will result in greater consumption of lower margin drugs.
- Consolidation and vertical integration of medicine wholesale and retail markets is increasing.
- Drugmakers may improve market access in Central Europe but revenues may be repressed.
Transformation of the pharmaceutical supply chain